“Antiangiogenic activity of zoledronic acid: inhibition of the VEGF-VEGFR-2 autocrine loop in the endothelial cells of patients with multiple myeloma”, Hematol Meeting Rep, vol. 2, no. 3, Jun. 2009, doi: 10.4081/hmr.v2i3.376.